Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crystalloid or colloid coload plus prophylactic norepinephrine during cesarean section
ChiCTR2500097324Phase 4Not yet recruiting
- Sponsor
- General Hospital of Ningxia Medical University
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of norepinephrine in hypotension (3 arms), sponsored by General Hospital of Ningxia Medical University. Primary endpoints: Umbilical artery pH and Umbilical artery base excess. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
norepinephrine
03
Conditions
hypotension
Beyond the preview
Go deeper on ChiCTR2500097324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500097324.